Landos Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch LABP and buy or sell other stocks, ETFs, and their options commission-free!About LABP
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of novel, oral, once-daily therapeutics for patients with certain immunology diseases. It offers NX-13, a novel, oral, gut-restricted compound for the treatment of inflammatory bowel disease, which targets the NLRX1 pathway.
CEOGregory Oakes, MBA
CEOGregory Oakes, MBA
Employees—
Employees—
HeadquartersRoanoke, Virginia
HeadquartersRoanoke, Virginia
Founded2017
Founded2017
Employees—
Employees—
LABP Key Statistics
Market cap71.47M
Market cap71.47M
Price-Earnings ratio-5.74
Price-Earnings ratio-5.74
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$22.94
52 Week high$22.94
52 Week low$21.90
52 Week low$21.90
Stock Snapshot
With a market cap of 71.47M, Landos Biopharma(LABP) trades at $3.39. The stock has a price-to-earnings ratio of -5.74.
During the trading day, Landos Biopharma(LABP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Landos Biopharma(LABP) stock has reached 0.
Over the past 52 weeks, Landos Biopharma(LABP) stock has traded between a high of $22.94 and a low of $21.90.
Over the past 52 weeks, Landos Biopharma(LABP) stock has traded between a high of $22.94 and a low of $21.90.
People also own
Based on the portfolios of people who own LABP. This list is generated using Robinhood data, and it’s not a recommendation.